Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy
Current Issues in Molecular Biology · 10.03.2025 · 47 (3) · 179
DOI: 10.3390/cimb47030179 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 10.03.2025. Verfasst von Craig Grobbelaar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pretoria.
Abstract (Originalsprache)
In pancreatic cancer (PC), vascular endothelial growth factor (VEGF) and its primary receptor, vascular endothelial growth factor receptor (VEGFR)-2, are central drivers of angiogenesis and metastasis, with their overexpression strongly associated with poor prognosis. In some PC patients, VEGF levels correlate with disease stage, tumor burden, and survival outcomes. However, therapies targeting VEGF and VEGFR-2, including tyrosine kinase inhibitors (TKIs) and monoclonal antibodies, have demonstrated limited efficacy, partly due to the emergence of resistance mechanisms. Resistance appears to stem from the activation of alternative vascularization pathways. This review explores the multifaceted roles of VEGFRs in pancreatic cancer, including VEGFR-1 and VEGFR-3. Potential strategies to improve VEGFR-targeting therapies, such as combination treatments, the development of more selective inhibitors, and the use of biomarkers, are discussed as promising approaches to enhance treatment efficacy and outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa.
- Department of Pharmacology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria 0002, South Africa.
ORCID-Profile: Craig Grobbelaar, Vanessa Steenkamp
Förderung
- University of Pretoria
Zitieren
APA
Grobbelaar, C., Steenkamp, V., & Mabeta, P. (2025). Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy. Current Issues in Molecular Biology, 47(3), 179. https://doi.org/10.3390/cimb47030179
Vancouver
Grobbelaar C, Steenkamp V, Mabeta P. Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy. Current Issues in Molecular Biology. 2025;47(3):179. doi:10.3390/cimb47030179
BibTeX
@article{Grobbelaar2025,
author = {Grobbelaar, Craig and Steenkamp, Vanessa and Mabeta, Peace},
title = {Vascular Endothelial Growth Factor Receptors in the Vascularization of Pancreatic Tumors: Implications for Prognosis and Therapy},
journal = {Current Issues in Molecular Biology},
year = {2025},
volume = {47},
number = {3},
pages = {179},
doi = {10.3390/cimb47030179}
}
EUVIMED